Date Filed | Type | Description |
08/07/2023 |
4
| Silber Christopher (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 330,000 options to buy
@ $6.16, valued at
$2M
|
|
08/07/2023 |
3
| Silber Christopher (Chief Medical Officer) has filed a Form 3 on Vigil Neuroscience, Inc. |
06/09/2023 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
06/09/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
06/09/2023 |
4
| Koenig Gerhard (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
06/09/2023 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
06/09/2023 |
4
| Vitorovic Stefan (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
06/09/2023 |
4
| Booth Bruce (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
06/09/2023 |
4
| Budd Haeberlein Samantha L. (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
05/09/2023 |
4
| Budd Haeberlein Samantha L. (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 30,694 options to buy
@ $9.65, valued at
$296.2k
|
|
05/09/2023 |
3
| Budd Haeberlein Samantha L. (Director) has filed a Form 3 on Vigil Neuroscience, Inc. |
02/27/2023 |
4
| Gray David L. F. (Chief Science Officer) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 267,000 options to buy
@ $12.09, valued at
$3.2M
|
|
02/27/2023 |
3
| Gray David L. F. (Chief Science Officer) has filed a Form 3 on Vigil Neuroscience, Inc. |
11/22/2022 |
4
| Papapetropoulos Spyros (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Sold 300 shares
@ $14, valued at
$4.2k
Exercised 300 options to buy
@ $1.89, valued at
$567 |
|
07/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/28/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/13/2022 |
4
| Vitorovic Stefan (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 12,155 options to buy
@ $3.1, valued at
$37.7k
|
|
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Thackaberry Evan (SVP, Head of Early Development) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Bought 1,500 shares
@ $4, valued at
$6k
|
|
05/04/2022 |
4
| Verni Christopher (General Counsel) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Bought 4,000 shares
@ $3.7686, valued at
$15.1k
|
|
05/04/2022 |
4
| Magovcevic-Liebisch Ivana (President and CEO) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Bought 4,000 shares
@ $3.6097, valued at
$14.4k
Bought 1,000 shares
@ $3.9402, valued at
$3.9k
|
|
05/04/2022 |
4
| Ziolkowski Jennifer Lynn (CFO) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Bought 4,000 shares
@ $3.7744, valued at
$15.1k
|
|
05/04/2022 |
4
| Papapetropoulos Spyros (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Bought 4,000 shares
@ $3.3978, valued at
$13.6k
|
|
04/20/2022 |
4
| Verni Christopher (General Counsel) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 150,000 options to buy
@ $7.06, valued at
$1.1M
|
|
04/20/2022 |
3
| Verni Christopher (General Counsel) has filed a Form 3 on Vigil Neuroscience, Inc. |
04/20/2022 |
4
| Thistle Mary (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Granted 24,309 options to buy
@ $6.8, valued at
$165.3k
|
|
04/20/2022 |
3
| Thistle Mary (Director) has filed a Form 3 on Vigil Neuroscience, Inc. |
03/28/2022 |
4
| Thorp Clay (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns:
| Bought 3,000 shares
@ $7.2014, valued at
$21.6k
|
|
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|